Clinical Trial Update: Ethiopia Antimalarial in Vivo Efficacy Study 2012 [Phase 4]

View source ↗

Summary

This is a completed Phase 4 clinical trial conducted in Ethiopia evaluating an antimalarial for in vivo efficacy against Plasmodium vivax malaria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plasmodium Vivax Malaria

Drugs mentioned

• Unspecified antimalarial

Snippet

Sponsor: Centers for Disease Control and Prevention | Conditions: Plasmodium Vivax Infection | Phase 4 | Status: COMPLETED